Description
Anti-RALT/Mig-6 (SG-16) is developed in rabbit using
as immunogen a synthetic peptide corresponding to
amino acids 431-446 of rat RALT, conjugated to KLH
via an N-terminal added cysteine
PTCD)
S
u
p
er
n
at
an
t
T
u
rb
id
it
y
(N
T
U
)
5E6 86% Viability 10E6 86% Viability 15E6 86% Viability
Figure 2. Total Cell Density Impacts on Dosing
Srivastava S: Diagnostic potential of serum proteomic
patterns in prostate cancer. J. Urol. 2003, 170:442–446.
64. Rai A, Zhang Z, Rosenzweig J, Shih I, Pham T, Fung E, Sokoll L,
Chan D: Proteomic approaches
epimerization, and the subsequent
reopening of the ring to yield undesirable b-aspartyl peptides [446]. In
Fmoc chemistry, it was originally believed this could be overcome by the
use of Asp(OtBu) [47
ASTM D 86; IP 23 / ISO 3405 (168.5-360.1 °C)
CRMDIGO Distillation Standard
CRMDIGA Distillation Standard, ASTM D 86; NF EN ISO 3405 (30-178.6 °C)
CRMUDIKR Distillation Standard, ASTM D 86; NF EN
Receptor is an Auxillary Protein for Thyroid Hormone and Retinoic
Acid Receptors
Nature 355, 441-446 (1992)
(9) Zhang, X-K; Lehmann, J; Hoffmann, B; Dawson, M; Cameron, J; Graupner, G;
Hermann
Receptor is an Auxillary Protein for Thyroid Hormone and Retinoic
Acid Receptors
Nature 355, 441-446 (1992)
(9) Zhang, X-K; Lehmann, J; Hoffmann, B; Dawson, M; Cameron, J; Graupner, G;
Hermann
Receptor is an Auxillary Protein for Thyroid Hormone and Retinoic
Acid Receptors
Nature 355, 441-446 (1992)
(9) Zhang, X-K; Lehmann, J; Hoffmann, B; Dawson, M; Cameron, J; Graupner, G;
Hermann
1 M3320 M y y n/d
443 MCH M8440 P y n/d n/d
444 Mcl-1 M8434 P y n/d n/d
445 MDC1 M2444 M y n/d n/d
446 MDM2 M8558 M n/d y n/d
447 MDM2 M4308 M y y y
448 MDM2 M7815 M